ENO2 and chronic kidney disease: Our finding, that higher levels of NSE in HD patients with poor outcome further strengthens the suggestion that NSE could be a potential marker for assessing the neurologic outcome, though it is important to stress that in acute events (e.g., stroke)47 NSE levels could differ from chronic situations like CKD.